Prevalence of primary HIV-1 drug resistance in pregnant women and in newly diagnosed adults at Tijuana General Hospital, Baja California, Mexico

International Journal of STD and AIDS

Volumn 18, Issue 4, 2007, Pages 235-238

  Viani, Rolando M ^a,b,c   Hsia, K ^a,b   Hubbard, P ^c   Ruiz Calderon, J ^d   Lozada, R ^d   Alvelais, J ^d   Gallardo, M ^d   Spector, S A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hospital General de Tijuana   (Mexico)

Author keywords

Early HIV infection; Genotype; HIV drug resistance; Mexico; Pregnant women; Prevalence of drug resistance; Risk factors

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MALE; MEXICO; PLASMA; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VIRUS MUTANT; CROSS-SECTIONAL STUDY; DRUG EFFECT; GENERAL HOSPITAL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HOSPITALS, GENERAL; HUMANS; MALE; MEXICO; OUTPATIENT CLINICS, HOSPITAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 34250665432     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207780658962     Document Type: Article

References (19)

1. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60
2. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002;288:181-8
3. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-94
4. del Rio C, Sepulveda J. AIDS in Mexico: lessons learned and implications for developing countries. AIDS 2002;16:1445-57
5. CENSIDA. Panorama Epidemiologico del VIH/SIDA e ITS en Mexico. 2005. Mexico City, Mexico: Secretaria de Salud, 2005. Available at: [www.salud. gob.mx/CONASIDA/]. Accessed 6 March 2006
6. Viani RM, Calderon JR, Van Pratt C, Lopez G, Spector SA. HIV prevalence during pregnancy in Tijuana, Baja California, Mexico. AIDS 2003;17:1113-14
7. Viani RM, Araneta MR, Ruiz-Calderon J, et al. Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection. J Acquir Immune Defic Syndr 2006;41:87-92
8. Escoto-Delgadillo M, Vazquez-Valls E, Ramirez-Rodriguez M, et al. Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico. HIV Med 2005;6:403-9
9. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42:2623-8
10. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18:295-307
11. Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: 2005. Top HIV Med 2005;13:51-7
12. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352:1873-83
13. Alarcon JO, Johnson KM, Courtois B, et al. Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS 2003;17:613-18
14. Johnson KM, Alarcon J, Watts DM, et al. Sexual networks of pregnant women with and without HIV infection. AIDS 2003;17:605-12
15. Wensing AM, van de Vijver DA, Angarano G, et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis 2005;192:958-66
16. Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L. Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon? Clin Infect Dis 2005;40:1350-4
17. Brindeiro RM, Diaz RS, Sabino EC, et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 2003;17:1063-9
18. Torti C, Bono L, Gargiulo F, et al. Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naive for anti-retrovirals. Clin Microbiol Infect 2004;10:826-30
19. Alexander CS, Dong W, Chan K, et al. HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort. AIDS 2001;15:601-7